Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement

Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement

Under-representation of patients from racial/ethnic minority groups in cancer clinical trials is a major barrier to health equity. Black patients are significantly less likely to be enrolled in clinical trials compared with non-Hispanic White (White) patients although they carry a disproportionate burden of cancer mortality, the shortest survival rates, and are more likely to be diagnosed at later stages. Further, medical mistrust and lack of awareness and complexity of clinical trials are barriers that reduce the likelihood of clinical trial participation. The objective of this pilot study is to understand the effect of a culturally tailored decision aid (previously developed by our research team) on 1) medical mistrust, 2) patient knowledge about clinical trials, and 3) decision-making self-efficacy and determine the acceptability of the decision aid among Black patients currently or ever been diagnosed with cancer.

This study will be conducted online through Qualtrics.

Participants will answer pre-test survey questions, watch the culturally tailored decision aid video [Fostering Opportunities in Research Using Marketing Strategies (FOR US)] intervention, then answer post-intervention survey questions.

Inclusion Criteria:

• Are 18 years of age or older
• Identify as Black/African- American
• Have Current or previous diagnosis of cancer
• Speak and understand English

Exclusion Criteria:

• Are younger than 18 years of age
• Do not identify as Black/African- American
• Do not have a current or previous diagnosis of cancer
• Are non - English-speaking